Cargando…
Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review
BACKGROUND: During the recent pandemic with the severe acute respiratory syndrome-corona virus‑2 the first messenger ribonucleic acid (mRNA) vaccines were approved. To facilitate mass vaccination, confidence of the general population in these new vaccines is mandatory, which is in turn strongly depe...
Autores principales: | Federspiel, Jan M., Ramsthaler, Frank, Kettner, Mattias, Mall, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297279/ https://www.ncbi.nlm.nih.gov/pubmed/35873498 http://dx.doi.org/10.1007/s00194-022-00587-9 |
Ejemplares similares
-
Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022) -
Atypical wound trajectory after a tangential pistol shot
por: Lux, Constantin, et al.
Publicado: (2022) -
Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
por: Akamine, Christine M., et al.
Publicado: (2022) -
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
por: Yihunie, Wubetu, et al.
Publicado: (2023) -
Retrograde dye perfusion of the proximal aorta – A postmortem technical study
por: Federspiel, Jan M., et al.
Publicado: (2022)